Insulin resistance may hold the key to Alzheimer's disease
Author:
- 20 February 2025
- journal article
- Published by Mark Allen Group in British Journal of Nursing
- Vol. 34 (4) , 202-206
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- True or false? Alzheimer’s disease is type 3 diabetes: Evidences from bench to bedsideAgeing Research Reviews, 2024
- The proteinopenia hypothesis: Loss of Aβ42 and the onset of Alzheimer’s DiseaseAgeing Research Reviews, 2023
- Lecanemab in Early Alzheimer’s DiseaseNew England Journal of Medicine, 2023
- Why press releases don’t tell the whole story2022
- An Ethical Argument for Ending Human Trials of Amyloid-Lowering Therapies in Alzheimer’s DiseaseAJOB Neuroscience, 2022
- The 20-Year Voyage Aboard the Journal of Alzheimer's Disease: Docking at ‘Type 3 Diabetes’, Environmental/Exposure Factors, Pathogenic Mechanisms, and Potential TreatmentsJournal of Alzheimer’s Disease, 2018
- Beta amyloid and hyperphosphorylated tau deposits in the pancreas in type 2 diabetesNeurobiology of Aging, 2010
- Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease – is this type 3 diabetes?Journal of Alzheimer’s Disease, 2005
- Diabetes Mellitus and Risk of Alzheimer Disease and Decline in Cognitive FunctionArchives of Neurology, 2004
- Increased Risk of Type 2 Diabetes in Alzheimer DiseaseDiabetes, 2004